2026年3月25日 上午10:38 UTC / 路透社
节点运行失败
美国参议员Jeanne Shaheen（新罕布什尔州民主党人）于2026年1月17日在丹麦哥本哈根与由参议员和众议员组成的美国代表团出席新闻发布会。Ritzau Scanpix/Ida Marie Odgaard/via REUTERS/File Photo 购买授权，在新标签页打开
3月25日（路透社）- Semafor周三援引对新罕布什尔州民主党参议员Jeanne Shaheen的采访报道称，美国两党参议员小组已就将一个月供应量的胰岛素价格上限定为35美元达成协议。
据Semafor报道，Shaheen正紧急推动在她退出国会前通过立法降低胰岛素成本，她与参议员Susan Collins、Raphael Warnock和John Kennedy合作。
订阅路透社健康动态新闻通讯，了解最新的医学突破和医疗趋势。点击此处注册。
Rishabh Jaiswal报道于班加罗尔；Andrew Heavens编辑
我们的标准：汤姆森路透社信托原则，在新标签页打开
US Senators reach deal on capping insulin costs at $35 per month, Semafor reports
March 25, 2026 10:38 AM UTC / Reuters
节点运行失败
U.S. Senator Jeanne Shaheen (D-NH) attends a press conference with an American delegation, consisting of senators and members of the House of Representatives, in Copenhagen, Denmark January 17, 2026. Ritzau Scanpix/Ida Marie Odgaard/via REUTERS/File Photo Purchase Licensing Rights, opens new tab
March 25 (Reuters) – A bipartisan group of U.S. senators has reached a deal on capping the price of a month’s supply of insulin at $35, Semafor reported on Wednesday, citing an interview with New Hampshire Democrat Senator Jeanne Shaheen.
Shaheen is making an urgent push to pass legislation to reduce the cost of insulin before her retirement from Congress, teaming with Senators Susan Collins, Raphael Warnock and John Kennedy, according to the Semafor report.
Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.
Reporting by Rishabh Jaiswal in Bengaluru; Editing by Andrew Heavens
Our Standards: The Thomson Reuters Trust Principles., opens new tab
发表回复